# Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT

> **NCT06061094** · PHASE2 · RECRUITING · sponsor: **Goethe University** · enrollment: 220 (estimated)

## Conditions studied

- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Imatinib
- **DRUG:** Ponatinib
- **DRUG:** Blinatumomab
- **OTHER:** Indication for stem cell transplantation

## Key facts

- **NCT ID:** NCT06061094
- **Lead sponsor:** Goethe University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-14
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06061094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06061094, "Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06061094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*